Relationships Between Oncogenes and Growth Control

  • A. Leutz
  • T. Graf
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 95 / 2)


In recent years we have witnessed a revolution in the understanding of the mechanisms which regulate mammalian cell growth. This applies both to normal cells, in which growth is tightly controlled, as well as to cancer cells, which divide in an uncontrolled fashion. With the advent of molecular biology a number of genes have been identified whose products are involved in regulating normal cell growth. In parallel research 40–60 genes that are capable of inducing a transformed phenotype and that have been termed “on-cogenes” have been identified. It is now clear that growth control genes on the one hand and oncogenes on the other are largely one and the same. Although unequivocal evidence for this notion was obtained only recently, the concept itself emerged gradually beginning with the discovery of viral oncogenes (v-onc genes) and the fact that these genes represent cell-derived sequences (termed protooncogenes, cellular oncogenes, or c-onc genes).


Mouse Mammary Tumor Virus Avian Sarcoma Virus Epidermal Growth Factor Recep Simian Sarcoma Virus Avian Erythroblastosis Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL (1985) The c-myc oncogene driven by immunoglobulin enhancers induce lymphoid malignancy in transgenic mice. Nature 318: 533–538PubMedCrossRefGoogle Scholar
  2. Adari H, Lowy DR, Willumsen BM, Der CJ, McCormick F (1988) Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science 240: 518–521PubMedCrossRefGoogle Scholar
  3. Adkins B, Leutz A, Graf T (1984) Autocrine growth induced by src-related oncogenesin transformed chicken myeloid cells. Cell 39: 439–445Google Scholar
  4. Almendral JM, Sommer D, MacDonald-Bravo H, Burckhardt J, Perera J, Bravo R (1988) Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol 8: 2140–2148PubMedGoogle Scholar
  5. Andres A-C, van der Valk MA, Schonenberger CA, Fliickiger F, LeMeur M, Gerlinger P, Groner B (1988) Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice. Genes Dev 2: 1486–1495PubMedCrossRefGoogle Scholar
  6. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M (1987) Phorbol ester inducible genes contain a common cis element recognized by a TPA-modulated transacting factor. Cell 49: 729–739PubMedCrossRefGoogle Scholar
  7. Angel P, Hattori K, Smeal T, Karin M (1988 a) The jun proto-oncogene is positively autoregulated by its product, jun/APl, Cell 55: 875–885CrossRefGoogle Scholar
  8. Angel P, Allegretto EA, Okino ST, Hattori K, Boyle WJ, Hunter T, Karin M (1988 b) Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 332: 166–171CrossRefGoogle Scholar
  9. Armelin HA, Armelin MCS, Kelly K, Stewart T, Leder P, Cochran BH, Stiles CD (1984) Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature 310: 655–660PubMedCrossRefGoogle Scholar
  10. Assoian RK, Grotendorst GR, Miller DM, Sporn MB (1984) Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature 309: 804PubMedCrossRefGoogle Scholar
  11. Balduzzi PC, Notter MDF, Morgan HR, Shibuya M (1981) Some biological properties of two new avian sarcoma viruses. J Virol 40: 268–275PubMedGoogle Scholar
  12. Barbacid M (1987) ras genes. Annu Rev Biochem 56:779–827PubMedCrossRefGoogle Scholar
  13. Bargmann CI, Hung M-C, Weinberg RA (1986 a) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p 185. Cell 45: 649–657CrossRefGoogle Scholar
  14. Bargmann CI, Hung M-C, Weinberg RA (1986 b) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319: 226–230Google Scholar
  15. Barker WC, Dayhoff MO (1982) Viral src gene products are related to the catalytic chain of mammalian cAMP-dependent protein kinase. Proc Natl Acad Sci USA 68: 1520–1524Google Scholar
  16. Barletta C, Pellici P, Kenyon L, Smith SD, Dalla-Favera R (1987) Relationship between c-myb locus and the 6q-chromosomal aberration in leukemias and lymphomas. Science 287: 1064–1067CrossRefGoogle Scholar
  17. Beard JW (1963) Avian virus growths and their etiological agents. Cancer Res 7: 1–127CrossRefGoogle Scholar
  18. Begg AM (1927) A filterable endothelioma of the fowl. Lancet 1: 912–915CrossRefGoogle Scholar
  19. Beimling P, Benter T, Sander T, Moelling K (1985) Isolation and characterization of he human cellular myc gene product. Biochemistry 24: 6349–6355PubMedCrossRefGoogle Scholar
  20. Benedict SH, Maki Y, Vogt PK (1985) Avian retrovirus SI 3: properties of the genome and of the transformation-specific protein. Virology 145: 154–164PubMedCrossRefGoogle Scholar
  21. Bentley DL, Groudine M (1986) A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature 321: 702–706PubMedCrossRefGoogle Scholar
  22. Bentley DL, Groudine M (1988) Sequence requirements for premature termination of transcription in the human c-myc gene. Cell 53: 245–256PubMedCrossRefGoogle Scholar
  23. Berridge MJ (1987) Inositol lipids and cell proliferation. Bioch Biophys Acta 907: 33–45Google Scholar
  24. Berridge MJ, Irvine RF (1984) Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312: 315–321PubMedCrossRefGoogle Scholar
  25. Besmer P, Snyder HW Jr, Murphy JE, Hardy WD Jr, Parodi (1983) The Parodi-Irgens feline sarcoma virus and simian sarcoma virus have homologous oncogenes, but in different contexts of the viral genomes. J Virol 46: 603–613Google Scholar
  26. Besmer P, Murphy JE, George PC, Qiu F, Gergold PJ, Lederman L, Snyder HW Jr, Brodeur D, Zuckerman EE, Hardy WD (1986 a) A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320: 415–21CrossRefGoogle Scholar
  27. Besmer P, Lader E, George PC, Bergold PJ, Qui F-H, Zuckerman EE, Hardy WD (1986 b) A new acute transforming feline retrovirus with fms homology specifies a C-terminally truncated version of the c-fms protein that is different from SM-feline sarcoma virus v-fms protein. J Virol 60: 194–203Google Scholar
  28. Betsholtz C, Johnsson A, Heldin C-H, Westermark B (1985) Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc Natl Acad Sci USA 83: 6440–6444CrossRefGoogle Scholar
  29. Beug H, Hayman MJ (1984) Temperature-sensitive mutants of avian erythroblastosis virus: surface expression of the erbB product correlates with transformation. Cell 36: 963–972PubMedCrossRefGoogle Scholar
  30. Beug H, Claviez M, Jockusch B, Graf T (1978) Differential expression of Rous sarcoma virus specific transformation parameters in enucleated cells. Cell 14: 843–857Google Scholar
  31. Beug H, v. Kirchbach A, Daderlein G, Conscience JF, Graf T (1979) Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell 18: 375–390PubMedCrossRefGoogle Scholar
  32. Beug H, Palmieri S, Freudenstein C, Zentgraf H, Graf T (1982 a) Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by is mutants of avian erythroblastosis virus. Cell 28: 907–919Google Scholar
  33. Beug H, Hayman MJ, Graf T (1982 b) Myeloblasts transformed by the avian acute leukemia virus E26 are hormone-dependent for growth and for the expression of a putative m-containing protein, p 135 E26. EMBO J 1: 1069–1073Google Scholar
  34. Beug H, Leutz A, Kahn P, Graf T (1984) ts mutants of E26 leukemia virus allow transformed myeloblasts, but not erythroblasts or fibroblasts, to differentiate at the non- permissive temperature. Cell 39: 579–588PubMedCrossRefGoogle Scholar
  35. Beug H, Blundell P, Graf T (1987) Reversibility of differentiation and proliferative capacity in avian myelomonocytic cells transformed by ts E26 leukemia virus. Genes Dev 1: 277–286Google Scholar
  36. Biedenkapp H, Borgmeyer U, Sippel AE, Klempnauer K-H (1988) Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 335: 835–837PubMedCrossRefGoogle Scholar
  37. Birchmeier C, Birnbaum D, Waitches G, Fasano O, Wigler M (1986) Characterization of an activated human c-ros gene. Mol Cell Biol 6: 3109–3116PubMedGoogle Scholar
  38. Bister K (1984) Molecular biology of avian acute leukaemia viruses. In Goldman JM, Jarrett O (eds) Mechanisms of viral leukaemogenesis. Churchill Livingstone, Edinburgh (Leukaemia and lymphoma research, vol 1 )Google Scholar
  39. Bister K, Enrietto P, Graf T, Hayman M (1983) The transforming gene of avian acute leukemia virus MC29. In: Neth R etal. Haematology and blood transfusion. Mechanism of malignant transformation, Springer, Berlin Heidelberg New York (Modern trends in human leukemia, vol 5 )Google Scholar
  40. Biswas R, Basu M, Sen-Majumdar A, Das M (1985) Intrapeptide autophosphorylation of the epidermal growth factor receptor: regulation of kinase catalytic function by receptor dimerization. Biochemistry 24: 3795–3802PubMedCrossRefGoogle Scholar
  41. Blanchard J-M, Piechacyzk M, Dani C, Chambard J-C, Franchi A, Pouyssegur J, Jeanteur P (1985) C-myc gene is transcribed at high rate in Go-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors. Nature 317: 443–445Google Scholar
  42. Bohmann D, Bos TJ, Nishimura T, Vogt PK, Tjian R (1987) Human protooncogene c- jun encodes a protein with antigenic and enhancer binding properties of transcription factor AP-1. Science 238: 1386–1392PubMedCrossRefGoogle Scholar
  43. Bolen JB, Thiele CJ, Israel MA, Yonemoto W, Lipsich LA, Brugge JS (1984) Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation. Cell 38: 767–777PubMedCrossRefGoogle Scholar
  44. Bollag GE, Roth RA, Beaudoin J, Mochly-Rosen D, Koshland DE Jr (1986) Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Sci USA 83: 5822–5824CrossRefGoogle Scholar
  45. Bos JL (1988) The ras gene family and human carcinogenesis. Mutat Res (Elsevier) 195: 255–271Google Scholar
  46. Bos T, Bohmann D, Tsuchie H, Tjian R, Vogt P (1988) v-jun encodes a nuclear protein with enhancer binding proteins of AP-1. Cell 52: 705–712Google Scholar
  47. Boulukos KE, Pognonec P, Begue A, Galibert F, Gesquiere D, Stehelin D, Ghysdael J (1988) Identification in chickens of an evolutionary conserved cellular ets-2 gene (c- ets-2) encoding nuclear proteins related to the products of the c-ets proto-oncogene. EMBO J 7: 697–705PubMedGoogle Scholar
  48. Boyle WJ, Lampert MA, Lipsick JS, Baluda MA (1984) Avian myeloblastosis virus and E26 virus oncogene products are nuclear proteins. Proc Natl Acad Sci USA 81: 4265–4269PubMedCrossRefGoogle Scholar
  49. Bravo R, Burckhardt J, Curran T, Miiller R (1985) Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes. EMBO J 5: 695–700Google Scholar
  50. Brown AM, Papkoff J, Fung YK, Shackleford GM, Varmus HE (1987) Identification of protein products encoded by the proto-oncogene int-1. Mol Cell Biol 7: 3871–3977Google Scholar
  51. Brown AMC, Wildin RS, Prendergast TJ, Varmus HE (1986) A retrovirus vector expressing the putative mammary oncogene int-1 causes partial transformation of a mammary epithelial cell line. Cell 46: 1001–1009PubMedCrossRefGoogle Scholar
  52. Browning PJ, Bunn HF, Cline A, Shuman M, Nienhuis AW (1986) Replacement of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential. Proc Natl Acad Sci USA 83: 7800–7804PubMedCrossRefGoogle Scholar
  53. Büscher M, Rahmsdorf HJ, Liftin M, Karin M, Herrlich P (1988) Activation of the c- fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. Oncogene 3: 301–311PubMedGoogle Scholar
  54. Cabrera CV, Alonso MC, Johnston P, Phillips RG, Lawrence PA (1987) Phenocopies induced with anti-sense RNA identify the wingless gene. Cell 50: 659–663PubMedCrossRefGoogle Scholar
  55. Cartwright CA, Kaplan PL, Cooper JA, Hunter T, Eckhart W (1986) Altered sites of tyrosine phosphorylation in pp60c-src associated with polyoma middle tumor antigen. Mol Cell Biol 6: 1562–1570PubMedGoogle Scholar
  56. Cartwright CA, Eckhart W, Simon S, Kaplan PL (1987) Cell transformation by pp60c- src mutated in the carboxy-terminal regulatory domain. Cell 49: 83–91PubMedCrossRefGoogle Scholar
  57. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikiwa V, Nishizuka Y (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor- promoting phorbol esters. J Biol Chem 257: 7847–7851PubMedGoogle Scholar
  58. Cavalieri P, Ruscio T, Tinoco R, Benedict S, Davis C, Vogt PK (1985) Isolation of three new avian sarcoma viruses: ASV9, ASV17, and ASV25. Virology, 143: 680–683PubMedCrossRefGoogle Scholar
  59. Chang EH, Gonda MA, Ellis RW, Scolnick EM, Lowy DR (1982) Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. Proc Natl Acad Sci USA 79: 4848–4852PubMedCrossRefGoogle Scholar
  60. Chavrier P, Zerial M, Lemaire P, Almendral J, Bravo R, Charnay P (1988) A gene encoding a protein with zinc fingers is activated during G0/G1 transition in cultured cells. EMBO J 7: 29–35PubMedGoogle Scholar
  61. Chiu R, Boyle W, Meek J, Smeal T, Hunter T, Karin M (1988) The c-fos protein interacts with c-Jun/AP-l to stimulate transcription of AP-1 responsive genes. Cell 54: 541–552PubMedCrossRefGoogle Scholar
  62. Clark SS, McLaughlin J, Crist WM, Champlin R, Witte O (1987) Unique forms of the abl tyrosine kinase distinguish Ph’-positive CML from Ph’-positive ALL. Science 235: 85–88PubMedCrossRefGoogle Scholar
  63. Clarke ME, Kukowska-Latallo JF, Westin E, Smith M, Prochownik EV (1988) Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol 8: 884–892PubMedGoogle Scholar
  64. Cochet C, Gill GN, Meisenhelder J, Cooper J A, Hunter T (1984) C-kinase phosphory- lates the epidermal growth factor receptor and reduces its epidermal growth factor- stimulated tyrosine protein kinase activity. J Biol Chem 259: 2553–2558PubMedGoogle Scholar
  65. Cochran BH, Reffel AC, Stiles CD (1983) Molecular cloning of gene sequences regulatd by platelet-derived growth factor. Cell 33: 939–947PubMedCrossRefGoogle Scholar
  66. Cochran BH, Zullo J, Verma IM, Stiles CD (1984) Expression of the c-fos oncogene and a newly discovered r-fos is stimulated by platelet-derived growth factor. Science 226: 1080–1082PubMedCrossRefGoogle Scholar
  67. Cohen DR, Curran T (1988) fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Mol Cell Biol 8: 2063–2069Google Scholar
  68. Cole MD (1986) The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 20: 361–384PubMedCrossRefGoogle Scholar
  69. Coll J, Righi M, de Taisne C, Dissous C, Gegonne A, Stehelin D (1983) Molecular cloning of the avian acute transforming retrovirus MH2 reveals a novel cell-derived sequence (y-mil) in addition to the myc oncogene. EMBO J 2 (12): 2189–2194PubMedGoogle Scholar
  70. Cooper CS, Park M, Blair DG, Tainsky MA, Huebener K, Croce CM, Vande Woude GF (1984) Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 311: 29–33PubMedCrossRefGoogle Scholar
  71. Cooper JA (in press) The src-family of protein-tyrosine kinases. In: Kemp B, Alewood PF (eds) Peptides and protein phosphorylation. CRC Pres, Boca RatonGoogle Scholar
  72. Coppola J A, Cole MD (1986) Constituive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature 320: 760–763PubMedCrossRefGoogle Scholar
  73. Cory S (1986) Activation of cellular oncogenes in hemopoietic cells by chromosome translocations. Adv Cancer Res 47: 189–234PubMedCrossRefGoogle Scholar
  74. Cory S, Harris AW, Langdon WY, Alexander WS, Corcoran LM, Palmiter RD, Pinkert CA, Brinster RL, Adams JM (1987) The myc oncogene and lymphoid neoplasia: from translocations to transgenic mice. Hamatol-Bluttransfus 31: 248–251Google Scholar
  75. Cotton PC, Brugge JS (1983) Neural tissues express high levels of the cellular src gene product pp60c-src. Mol Cell Biol 3: 1157–1162Google Scholar
  76. Courtneidge SA (1985) Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation. EMBO J 4: 1471–1477PubMedGoogle Scholar
  77. Courtneidge SA, Smith AE (1983) Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature 303: 435–439PubMedCrossRefGoogle Scholar
  78. Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A, Ullrich A (1985) Tyrosine kinase receptor with extensive homology to EGF receptors shares chromosomal location with neu oncogene. Science 230: 1132–1139PubMedCrossRefGoogle Scholar
  79. Coussens L, Van Beveren C, Smith D, Chen E, Mitchell RL, Isacke CM, Verma IM, Ullrich A (1986) Structural alteration of viral homologue of receptor protoon- cogene fms at carboxyl terminus. Nature 320: 277–280PubMedCrossRefGoogle Scholar
  80. Curran T, Franza BR Jr (1988) Fos andJun: the AP-1 connection. Cell 55: 395–397Google Scholar
  81. Curran T, Morgan JI (1988) Memories of fos. Bio Essays 7: 255–258Google Scholar
  82. Curran T, Verma IM (1984) The FBR murine osteosarcoma virus I. Molecular analysis and characterization of a 75,000 Da gag-fos fusion product. Virology 135: 218–228PubMedCrossRefGoogle Scholar
  83. Curran T, Miller AD, Zokas L, Verma IM (1984) Viral and cellular fos proteins: a comparative analysis. Cell 36: 257–268Google Scholar
  84. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD (1985) Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316: 823–826PubMedCrossRefGoogle Scholar
  85. Cuypers HT, Selten G, Quint W, Zijlstra M, Robanus-Maandag E, Boelens W, Van Wezenbeek P, Melief C, Berns A (1984) Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell 37: 141–150Google Scholar
  86. Davis RJ, Czech MP (1985) Platelet derived growth factor mimics phorbol diester action on epidermal growth factor receptor phosphorylation at threonine-654. Proc Natl Acad Sci USA 82: 4080–4084PubMedCrossRefGoogle Scholar
  87. Dean M, Levine RA, Campisi J (1986) C-myc regulation during retinoic acid-induced differentiation of F9 cells is post-transcirptional and associated with growth arrest. Mol Cell Biol 6: 518–524Google Scholar
  88. Delli-Bovi P, Curatola AM, Kern FG, Greco A, Ittmann M (1987) An oncogene isolated by transfection of Kaposi’s sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 50: 729–737CrossRefGoogle Scholar
  89. Delli-Bovi P, Curatola AM, Newman KM, Sato Y, Moscatelli D, Hewick RM, Rifkin DB, Basilico C (1988) Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell Biol 8: 2933–2941Google Scholar
  90. Dickson C, Peters G (1987) Potential oncogene product related to growth factors. Nature 326: 833PubMedCrossRefGoogle Scholar
  91. Dickson C, Smith R, Brookes S, Peters G (1984) Tumorigenesis by mouse mammary tumour virus: pro viral activation of a cellular gene in the common integration region int-2. Cell 37: 529–536PubMedCrossRefGoogle Scholar
  92. DiFiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, Richter-King C, Schlessinger J, Waterfield MD (1987) Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51: 1063–1070PubMedCrossRefGoogle Scholar
  93. Distel RJ, Ro HS, Rosen BS, Groves DL, Spiegelmann BM (1987) Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation oiofos. Cell 49: 835–844PubMedCrossRefGoogle Scholar
  94. Donner L, Fedele LA, Garon CF, Anderson SJ, Sherr CJ (1982) McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms). J Virol 41: 489–500PubMedGoogle Scholar
  95. Doolittle RF, Hunkapiller MW, Hood LE, Devare SG, Robbins KC, Aaronson SA, Antoniades HN (1983) Simian sacroma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221: 275–277PubMedCrossRefGoogle Scholar
  96. Downing JR, Rettenmier CW, Sherr CJ (1988) Ligand-induced tyrosine kinase activity of the colony-stimulating factor 1 receptor in a murine macrophage cell line. Mol Cell Biol 8: 1795–1799PubMedGoogle Scholar
  97. Downward J, Parker P, Waterfield MD (1984 a) Autophosphorylation sites on the receptor for epidermal growth factor. Nature 311: 483–485CrossRefGoogle Scholar
  98. Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD (1984 b) Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature 307: 521–527Google Scholar
  99. Duprey SP, Boettiger D (1985) Developmental regulation of c-myb in normal myeloid progenitor cells. Proc Natl Acad Sci USA 82: 6937–6941PubMedCrossRefGoogle Scholar
  100. Eick D, Piechazyk M, Henglein B, Blanchard J-M, Traub B, Kofler E, Wiest S, Lenoir GM, Kofler E, Wiest S, Lenoir GM, Bornkamm GW (1985) Aberrant c-myc of Burkitt’s lymphoma cells have longer half-lives. EMBO J 4: 3717–3725PubMedGoogle Scholar
  101. Eick D, Berger R, Polack A, Bornkamm GW (1987) Transcription of c-myc in human mononuclear cells is regulated by an elongation block. Oncogene 2: 61–65PubMedGoogle Scholar
  102. Eliyahu D, Raz A, Gruss P, Givol D, Oren M (1984) Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 312: 646–649PubMedCrossRefGoogle Scholar
  103. Evan GI, Hancock DC (1985) Studies on the interaction of the human c-myc protein with cell nuclei: p62 c-myc as a member of a discrete subset of nuclear proteins. Cell 43: 253–261PubMedCrossRefGoogle Scholar
  104. Farber E, Cameron R (1980) The sequential analysis of cancer development. Adv Cancer Res 31: 125–226PubMedCrossRefGoogle Scholar
  105. Feramisco JR, Gross M, Kamota T, Rosenberg M, Sweet RW (1984) Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38: 109–117PubMedCrossRefGoogle Scholar
  106. Finkel MP, Biskis BO, Jinkins PB (1966) Virus induction of osteosarcomas in mice. Science 151: 698–701PubMedCrossRefGoogle Scholar
  107. Finkel MP, Reilly CA Jr, Biskis BO, Grecco IL (1973) Bone tumor viruses. In: Saunders CL, Bush RH, Ballon JE, Mahlum CC (eds) Colston papers, Proceedings 24th Symposium Colston Research Society, vol 24. Butterworths, London, pp 353–366Google Scholar
  108. Finkel MP, Reilly CA Jr, Biskis BO (1975) Viral etiology of bone cancer. Front Radiat Ther Oncol 10: 28–39Google Scholar
  109. Finkel T, Der JJ, Cooper GM (1984) Activation of ras genes in human tumors does not affect localization, modification or nucleotide binding properties of p21. Cell 37: 151–158PubMedCrossRefGoogle Scholar
  110. Frankel AE, Neubauer RL, Fischinger PJ (1976) Fractionation of DNA nucelotide transcripts from Moloney sarcoma viruses and isolation of sarcoma virus-specific complementary DNA. J Virol 18: 481–490PubMedGoogle Scholar
  111. Frykberg L, Palmieri S, Beug H, Graf T, Hayman MJ, Vennström B (1983) Transforming capacities of avian erythroblastosis virus mutants deleted in the erb A or erbB oncogenes. Cell 32: 227–238Google Scholar
  112. Fung Y-KT, Shackleford GM, Brown AMC, Sanders G, Varmus HE (1985) Nucleotide sequence and expression in vitro of cDNA derived from mRNA of int-1, a provirally activated mouse mammary oncogene. Mol Cell Biol 5: 3337–3344PubMedGoogle Scholar
  113. Gamett D, Tracy S, Robinson H (1986) Differences in sequences encoding the carboxyl-terminal domain of the epidermal growth factor receptor correlate with differences in the disease potential of viral erbB genes. Proc Natl Acad Sci USA 83: 6053–6057PubMedCrossRefGoogle Scholar
  114. Gandrillon O, Jurdic P, Benchaibi M, Xiao J-H, Ghysdael J, Samarut J (1987) Expression of the v-erbA oncogene in chicken embryo fibroblasts stimulates their proliferation in vitro and enhances tumor growth in vivo. Cell 49: 687–697PubMedCrossRefGoogle Scholar
  115. Gazit A, Igarashi H, Chiù I-M, Srinivasan A, Yaniv A, Tronick SR, Robbins KC, Aaronson SA (1984) Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation. Cell 39: 89–97Google Scholar
  116. Gazzolo L, Mosco vici C, Moscovici MG, Samarut J (1979) Response of hematopoietic cells to avian acute leukemia viruses: effects on the differentiation of the target cells. Cell 16: 627–638PubMedCrossRefGoogle Scholar
  117. Geissler EN, Ryan MA, Housman DE (1988) The dominant-white spotting ( W) locus of the mouse encodes the c-kit proto-oncogene. Cell 55: 185–192Google Scholar
  118. Gerondakis S, Bishop JM (1986) Structure of the protein encoded by the chicken protooncogene c-myb. Mol Cell Biol 6: 3677–3684PubMedGoogle Scholar
  119. Gewirtz AM, Calabretta B (1988) A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 242: 1303–1306PubMedCrossRefGoogle Scholar
  120. Ghysdael J, Gegonne A, Pognonec P, Dermis D, LePrince D, Stehelin D (1986) Identification and preferential expression in thymic and bursal lymphocytes of a c- ets oncogene-encoded Mr 54,000 cytoplasmic protein. Proc Natl Acad Sci USA 83: 1714–1718PubMedCrossRefGoogle Scholar
  121. Gibbs JB, Sigal IS, Scolnick EM (1985) Biochemical properties of normal and on-cogenic ras p21. Trends Biochem Sci 9: 350–353CrossRefGoogle Scholar
  122. Gill GN, Kawamoto T, Cochet C, Le A, Sato JD, Masui H, McLeod C, Mendelsohn J (1984) Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem 259: 7755–7760PubMedGoogle Scholar
  123. Golay J, Introna M, Graf T (1988) A single point mutation in the v-ets oncogene affects both erythroid and myelomonocytic cell differentiation. Cell 55: 1147–1158Google Scholar
  124. Golden A, Nemeth SP, Brugge JS (1986) Blood platelets express high levels of the ppöOc-src specific tyrosine kinase activity. Proc Natl Acad Sci USA 83: 852–856PubMedCrossRefGoogle Scholar
  125. Gould K, Hunter T (1988) Platelet-derived growth factor induced multisite phosphorylation of pp60c-rc increases its tyrosine kinase activity. Mol Cell Biol 8: 3345–3356PubMedGoogle Scholar
  126. Gould KL, Woodgett JR, Cooper JA, Buss JE, Shalloway D, Hunter T (1985) Protein kinase C phosphorylates pp60-src at a novel site. Cell 42: 849–857PubMedCrossRefGoogle Scholar
  127. Graf T (1973) Two types of target cells for transformation with avian myelocytomato-sis virus. Virology 54:398–113CrossRefGoogle Scholar
  128. Graf T, Stehelin D (1982) Avian leukemia viruses. Oncogenes and genome structure. BBA Rev Cancer 651:245–271Google Scholar
  129. Graf T, v. Weizsäcker F, Grieser S, Coll J, Stehelin D, Patschinsky T, Bister K, Bechade C, Calothy G, Leutz A (1986) V-mil induces autocrine growth and enhances tumorigenicity in v-myc transformed avian macrophages. Cell 100:357–364Google Scholar
  130. Graf T, Beug H (1978) Avian leukemia viruses: interaction with their target cells in vivo and in vitro. BBA Revs Cancer, 516:269–299.Google Scholar
  131. Graf T, Adkins B, Leutz A, Beug H, Kahn P (1985) Cooperativity between “primary” and “auxiliary” oncogenes of defective avian leukemia viruses. In: Marks PA (ed) Bristol-Myers Cancer Symposia, Genetics, Cell Differentiation, and Cancer, vol 7. Academic Press, New York, pp 171–182Google Scholar
  132. Graf T, v. Kirchbach A, Beug H (1981) Characterization of the hematopoietic target cells of AEV, MC29 and AMV avian leukemia viruses. Exptl Cell Res 131:331–343CrossRefGoogle Scholar
  133. Green S, Chambon P (1986) A superfamily of potentially oncogenic hormone receptors. Nature 324: 615–617PubMedCrossRefGoogle Scholar
  134. Greenberg ME, Ziff EB (1984) Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311: 433–438PubMedCrossRefGoogle Scholar
  135. Greenberg ME, Hermanowski AL, Ziff EB (1986) Effect of protein synthesis inhibitors on growth factor activation of c-fos, and actin gene transcription. Mol Cell Biol 6: 1050–1057PubMedGoogle Scholar
  136. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36: 93–99PubMedCrossRefGoogle Scholar
  137. Halazonetis TD, Georgopoulos K, Greenberg ME, Leder P (1988) c-jun dimerizes withitself and with c-fos, forming complexes of different DNA binding affinities. Cell 55: 917–924Google Scholar
  138. Hampe A, Gobet H, Sherr CJ, Galibert F (1984) Nucleotide sequence of the feline retroviral oncogene v-fms shows unexpected homology with oncogenes encoding tyrosine-kinase specific protein kinases. Proc Natl Acad Sci USA 81: 85–89PubMedCrossRefGoogle Scholar
  139. Hanley MR, Jackson T (1987) Transformer and transducer. Nature 328: 668–669PubMedCrossRefGoogle Scholar
  140. Hann SR, Eisenman RN (1984) Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol Cell Biol 4: 2486–2497PubMedGoogle Scholar
  141. Hannink M, Donoghue DJ (1986) Cell surface expression of membrane-anchored v-sis gene products: glycosylation is not required for cell surface transport. J Cell Biol 103: 2311–2322PubMedCrossRefGoogle Scholar
  142. Hayman MJ, Kitchener G, Vogt PK, Beug H (1985) The putative transforming protein of SI3 avian erythroblastosis virus is a transmembrane glycoprotein with an as-sociated protein kinase activity. Proc Natl Acad Sci USA 82: 8237–8241PubMedCrossRefGoogle Scholar
  143. Hayman MJ, Kitchener G, Knight J, McMahon J, Watson R, Beug H (1986) Autophosphorylation of v-erbB does not correlate with cell transformation. Virology 150: 270–275PubMedCrossRefGoogle Scholar
  144. Hayward WS, Neel BG, Astrin SM (1981) ALV-induced lymphoid leukosis: activation of a cellular one gene by promoter insertion. Nature 290: 475–480PubMedCrossRefGoogle Scholar
  145. Heikkila R, Schwab G, Wickstrom E, Loke SL, Pluznik DH, Watt R, Neckers LM (1987) A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from GO to Gl. Nature 328: 445–449PubMedCrossRefGoogle Scholar
  146. Heldin CH, Betsholtz C, Claesson-Welsh L, Westermark B (1987) Subversion of growth regulatory pathways in malignant transformation. Biochim Biophys Acta 907: 219–244PubMedGoogle Scholar
  147. Hermans A, Heisterkamp N, von Lindern M, van Baal S, Meijer D, van der Pias D, Wiedermann LM, Groffen J, Bootsma D, Grosveld G (1987) Unique fusion of bcr and c-abl genes in Philadelphia positive acute lymphoblastic leukemia. Cell 51: 33–40PubMedCrossRefGoogle Scholar
  148. Holt JT, Gopal TV, Moulton AD, Nienhuis W (1986) Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc Natl Acad Sci USA 83: 4794–4798PubMedCrossRefGoogle Scholar
  149. Housey GM, Johnson MD, Hsiao WLW, O’Brian CA, Murphy JP, Kirschmeier P, Weinstein IB (1988) Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52: 343–354PubMedCrossRefGoogle Scholar
  150. Huang JS, Huang SS, Deuel TF (1984) Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors. Cell 39: 79–87PubMedCrossRefGoogle Scholar
  151. Huleihel M, Goldsborough M, Cleveland JL, Gunnell M, Bonner T, Rapp UR (1986) Characterization of murine A-raf a new oncogene related to the v-raf oncogene. Mol Cell Bil 6: 3934–3938Google Scholar
  152. Hunter T, Ling N, Cooper JA (1984) Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature 311: 480–483PubMedCrossRefGoogle Scholar
  153. Iba H, Takeya T, Cross FR, Hanafusa T, Hanafusa H (1984) Rous sarcoma virus variants that carry the cellular src gene instead of the viral src gene cannot trans-form chicken embryo fibroblasts. Proc Natl Acad Sci USA 81: 4424–4428PubMedCrossRefGoogle Scholar
  154. Ishikawa F, Takaku F, Nagao M, Sugimura T (1987) Rat c-raf oncogene activation by a rearrangement that produces a fused protein. Mol Cell Biol 7: 1226–1232PubMedGoogle Scholar
  155. Jackowski S, Rettenmier CW, Sherr CJ, Rock CO (1986) A guanine nucleotide- dependent phosphatidylinositol-4,5-diphosphate phospholipase C in cells trans-formed by the v-fms and v-fes oncogenes. J Biol Chem 261: 4978–4985PubMedGoogle Scholar
  156. Jackson TR, Blair LA, Marshall J, Goedert M, Hanley MR (1988) The mas oncogene encodes an angiotensin receptor. Nature 335: 437–440PubMedCrossRefGoogle Scholar
  157. Jansen HW, Ruckert B, Lurz R, Bister K (1983) Two unrelated cell-derived sequences in the genome of avian leukemia and carcinoma inducing retrovirus. EMBO J 48: 61–73Google Scholar
  158. Jenkins JR, Sturzbecher HW (1988) The p53 oncogene. In: Reddy EP, Skala AM, Curran T (eds) The oncogene handbook. Elsevier, pp 403–423Google Scholar
  159. Jenkins JR, Rudge K, Curie GA (1984 a) Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature 312: 651–654CrossRefGoogle Scholar
  160. Jenkins JR, Rudge K, Redmond S, Wade-Evens A (1984 b) Cloning and expression of full length mouse cDNA sequences encoding the transformation associated protein p53. Nucl Acids Res 12: 5609–5626Google Scholar
  161. Jenkins JR, Rudge K, Chumakov P, Curie GA (1985) The cellular oncogene p53 can be activated by mutagenesis. Nature 317: 816–818PubMedCrossRefGoogle Scholar
  162. Jenuwein T, Muller R (1987) Structure-function analysis offos protein: a single amino acid change activates the immortalizing potential of v-fos. Cell 48: 647–657PubMedCrossRefGoogle Scholar
  163. Jenuwein T, Muller D, Curran T, Muller R (1985) Extended lifespan and tumorigenicity of nonestablished mouse connective tissue cells transformed by the fos oncogene of FBR-MSV. Cell 41: 629–637PubMedCrossRefGoogle Scholar
  164. Johnsson A, Betsholtz C, Heldin C-H, Westermark B (1985 b) Antibodies against platelet-derived growth factor inhibit acute transformation by simian sarcoma virus. Nature 317: 438–40Google Scholar
  165. Johnsson A, Betsholtz C, von der Helm K, Heldin C-H, Westermark B (1985) Platelet- derived growth factor agonist activity of a secreted form of the v-sis oncogene product. Proc Natl Acad Sci USa 82: 1721–1725PubMedCrossRefGoogle Scholar
  166. Johnsson A, Heldin C-H, Wasteson A, Westermark B, Deuel TF, Huang JS, Seeburg PH, Gray A, Ullrich A, Scrace G, Stroobant P, Waterfield MD (1984) The c-sis gene encodes a precursor of the B chain of platelet-derived growth factor. EMBO J 3: 921–928PubMedGoogle Scholar
  167. Josephs SF, Guo C, Ratner L, Wong-Staal F (1984) Human proto-oncogene nucleotide sequences corresponding to the transforming region of simian sarcoma virus. Science 223: 487–490PubMedCrossRefGoogle Scholar
  168. Jurdic P, Benchaibi M, Gandrillon O, Samarut J (1987) Transforming and mitogenic effects of avian leukemia virus E26 on chicken hematopoietic cells and fibroblasts, respectively, correlate with level of expression of the pro virus. J Virol 61: 3058–3065PubMedGoogle Scholar
  169. Kaczmareck L, Hyland JK, Watt R, Rosenberg M, Baserga R (1985) Microinjected c- myc as a competence factor. Science 228: 1313–1315CrossRefGoogle Scholar
  170. Kahn P, Frykberg L, Graf T (1986) Cooperativity between v-erbA- and v-src-related oncogenes in erythroid cell transformation. In: Deinhardt F (ed) Proceedings. Hamburg XII Symp for Comp Res on Leukemia and Rel Diseases. Berlin Heidelberg New York, pp 41–50Google Scholar
  171. Kan NC, Flordellis CS, Garon CF, Duesberg PH, Papas TS (1983) Avian carcinoma virus MH2 contains a transformation-specific sequence, MHT, and shares the myc sequence with MC29, CMII, and OKIO viruses. Proc Natl Acad Sci 80: 6566–6570PubMedCrossRefGoogle Scholar
  172. Katan M, Parker PJ (1988) Oncogenes and cell control. Nature 332: 203–205PubMedCrossRefGoogle Scholar
  173. Kato J, Takeya T, Grandon C, Iba H, Levy JB, Hanafusa H (1986) Amino acid substitutions sufficient to convert the nontransforming pp60c-src protein to a trans-forming protein. Mol Cell Biol 6: 4155–4160PubMedGoogle Scholar
  174. Keating MT, Williams LT (1988) Autocrine stimulation of intracellular PDGF recep-tors in v-sw-transformed cells. Science 239: 914–916PubMedCrossRefGoogle Scholar
  175. Kelloff GJ, Lane WT, Turner HC, Huebner RJ (1969) In vivo studies of the FBJ murine osteosarcoma virus. Nature 223: 1379–1380PubMedCrossRefGoogle Scholar
  176. Kelly K, Cochran BH, Stiles CD, Leder P (1983) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35: 603–610PubMedCrossRefGoogle Scholar
  177. Khazaie K, Dull TJ, Graf T, Schlessinger J, Ullrich A, Beug H, Vennstrom B (198) Truncation of the human EGF receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts. EMBO J 7: 3061–3071Google Scholar
  178. King CR, Kraus MH, Aaronson SA (1985 a) Amplification of a novel v-erZB-related gene in a human mammary carcinoma. Science 229: 974–976CrossRefGoogle Scholar
  179. King CR, Kraus MH, Aaronson SA (1985 b) Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNA’s. Nucl Acids Res 13: 8447–8486Google Scholar
  180. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M (1989) A ray-related gene with transformation suppressor activity. Cell 56: 77–84PubMedCrossRefGoogle Scholar
  181. Klein G (1987) The approaching era of the tumor suppressor genes. Science 238: 1539–1545PubMedCrossRefGoogle Scholar
  182. Klein G, Klein E (1985) Evolution of tumors and the impact of molecular oncology. Nature 315: 190–195PubMedCrossRefGoogle Scholar
  183. Klein G, Klein E (1986) Conditioned tumorigenicity of activated oncogenes. Cancer Res 46: 3211: 3224Google Scholar
  184. Klempnauer K-H, Symonds G, Evans GI, Bishop JM (1984) Subcellular localization of proteins encoded by oncogenes of avian myeloblastosis virus and avian leukemia virus E26 and by the chicken c-myb gene. Cell 37: 537–547PubMedCrossRefGoogle Scholar
  185. Klinken SP, Alexander WS, Adams JM (1988) Hematopoietic lineage switch: v-raf oncogene converts Ex-myc transgenic B cells into macrophages. Cell 53: 857–867PubMedCrossRefGoogle Scholar
  186. Kmiecik TE, Shalloway D (1987) Activation and suppression of pp60c-jrc transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49: 65–73PubMedCrossRefGoogle Scholar
  187. Knight J, Zenke M, Disela C, Kowenz E, Vogt P, Engel JD, Hayman MJ, Beug H (1988) Temperature-sensitive v-sea transformed erythroblasts: a model system to study gene expression during erythroid differentiation. Genes Dev 2: 247–258PubMedCrossRefGoogle Scholar
  188. Knudson AG Jr (1986) Genetics of human cancer. Annu Rev Genet 20: 231–251PubMedCrossRefGoogle Scholar
  189. Koda T, Sasaki A, Matsushima S, Kakinuma M (1987) A transforming gene, hst, found in NIH 3T3 cells transformed with DNA from three stomach cancers and a colon cancer. J Cancer Res 78 (4): 325–328Google Scholar
  190. Kouzarides T, Ziff E (1988) The role of the leucine zipper in the fos-jun interaction. Nature 336: 646–651PubMedCrossRefGoogle Scholar
  191. Kozma SC, Redmond SM, Fu XC, Saurer SM, Groner B, Hynes NE (1988) Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences. EMBO J 7: 147–154PubMedGoogle Scholar
  192. Kraus MH, Popescu NC, Amsbaugh SC, King CR (1987) Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6: 605–610PubMedGoogle Scholar
  193. Kris RM, Lax I, Gullick W, Waterfield MD, Ullrich A, Fridkin M, Schlessinger J (1985) Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein. Cell 40: 619–625PubMedCrossRefGoogle Scholar
  194. Kruijer W, Cooper JS, Hunter T, Verma IM (1984) Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature 312: 7330–7334CrossRefGoogle Scholar
  195. Kuehl WM, Bender TP, Stafford J, McClinton D, Segal S, Dmitrovsky E (1988) Expression and function of the c-myb oncogene during hematopoietic differention. Curr Top Microbiol Immunol 141: 318–323PubMedCrossRefGoogle Scholar
  196. Lachman HM, Skoultchi AI (1984) Expression of c-myc changes during differentiation of mouse erythroleukemia cells. Nature 82: 5323–5327Google Scholar
  197. Lachman HM, Hatton KS, Skoultchi AI, Schildkraut CL (1985) C-myc mRNA levels in the cell cycle change in mouse erythroleukemia cells following inducer treatment. Proc Natl Acad Sci USA 82: 5232–5327Google Scholar
  198. Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM (1988) Induction of protoon-cogene jun/AP–1 by serum and TPA. Nature 334: 629–631PubMedCrossRefGoogle Scholar
  199. Land H (1986) Oncogenes cooperate, but how? In: Kahn P, Graf T (eds) Oncogenes and growth control. Springer, Berlin Heidelberg New York, pp 304–311Google Scholar
  200. Land H, Chen AC, Morganstern JP, Parada LF, Weinberg RA (1986) Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol Cell Biol 6: 1917–1925PubMedGoogle Scholar
  201. Land H, Parada LF, Weinberg RA (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596–602PubMedCrossRefGoogle Scholar
  202. Landschulz WH, Johnson PF, McKnight SL (1988) The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240: 1759–1764PubMedCrossRefGoogle Scholar
  203. Lane DP, Crawford LV (1979) T-antigen is bound to a host protein in SV40-transformed cells. Nature 278: 261–263PubMedCrossRefGoogle Scholar
  204. Lang RA, Metcalf D, Gough NM, Dunn AR, Gonda TJ (1985) Expression of a hemopoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity. Cell 43: 531–542PubMedCrossRefGoogle Scholar
  205. Lau LF, Nathans D (1985) Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J 4: 3145–3151PubMedGoogle Scholar
  206. Lau LF, Nathans D (1987) Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci USA 84: 1182–1186PubMedCrossRefGoogle Scholar
  207. Lax I, Kris R, Sasson I, Ullrich A, Hayman MJ, Beug H, Schlessinger J (1985) Activation of c-erbB in avian leukosis virus-induced erythroblastosis leads to the expresion of a truncated EGF receptor kinase. EMBO J 4: 3179–3182PubMedGoogle Scholar
  208. Leal F, William LT, Robbins KC, Aaronson SA (1985) Evidence that the v-sis gene product transforms by interaction with the receptor for platelet-derived growth factor. Science 230: 327–330PubMedCrossRefGoogle Scholar
  209. Lech K, Anderson K, Brent R (1988) DNA-bound fos proteins activate transcription in yeast. Cell 52: 179–184PubMedCrossRefGoogle Scholar
  210. Leder A, Pattengale PK, Kuo A, Stewart TA, Leder P (1986) Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell 45: 485–495PubMedCrossRefGoogle Scholar
  211. Lee CK, Chan EW, Reilly CA Jr, Pahnke VA, Rockus G, Finkel MP (1979) In vitro properties of FBR murine osteosarcoma virus. Proc Soc Exp Biol Med 162: 214–220PubMedGoogle Scholar
  212. Lee W, Mitchell P, Tjian R (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49: 741–752PubMedCrossRefGoogle Scholar
  213. Lemaire P, Révélant O, Bravo R, Charnay P (1988) Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci USA 85: 4691–695PubMedCrossRefGoogle Scholar
  214. LePrince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C, Stehelin D (1983) A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 306: 395–397CrossRefGoogle Scholar
  215. LePrince D, Duterque-Coquillard M, Li P, Henry C, Flourens A, Debuire B, Stehelin D (1988) Alternative splicing within the chicken c-ets-1 locus: implications for transduction within the E26 retrovirus of the c-ets proto-oncogene. J Virol 62: 3233–3241Google Scholar
  216. Letterio JJ, Coughlin SR, Williams LT (1986) Pertussis toxin-sensitive pathway in the stimulation of c-myc expression and DNA synthesis by bombesin. Science 234: 1117–1119PubMedCrossRefGoogle Scholar
  217. Leutz A, Beug H, Graf T (1984) Purification and characterization of cMGF, a novel chicken myelomonocytic growth factor. EMBO J 3: 3191–3197Google Scholar
  218. Leutz A, Damm K, Sterneck E, Kowenz E, Ness S, Frank R, Gausepohl H, Pan Y-CE, Smart J, Hayman MJ, Graf T (1989) Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factor. EMBO J 8: 175–181Google Scholar
  219. Levy JA, Hartley JW, Rowe WP, Huebner RJ (1973) Studies of FBJ osteosarcoma virus in tissue culture. I. Biological characteristics of the “C”-type viruses. J Natl Cancer Inst 51: 525–539Google Scholar
  220. Levy J A, Kazan PL, Reilly CA Jr, Finkel MP (1987) FBJ osteosarcoma virus in tissue culture III. Isolation and characterization of non-virus producing FBJ-transformed cells. J Virol 26: 11–15Google Scholar
  221. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Water- field MD, Ullrich A, Schlessinger J (1985) Amplification enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 313: 144–147PubMedCrossRefGoogle Scholar
  222. Lidereau R, Callahan R, Dickson C, Peters G, Escot C, Ali IU (1988) Amplification of the int-2 gene in primary human breast tumours. Oncogene Res 2: 285–291PubMedGoogle Scholar
  223. Linzer DIH, Levine AJ (1979) Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40 transformed cells and uninfected embryonal carcinoma cells. Cell 17: 43–52PubMedCrossRefGoogle Scholar
  224. Linzer DIH, Nathans D (1983) Growth-related changes in specific mRNA’s of cultivated mouse cells. Proc Natl Acad Sci USA 80: 4271–1275PubMedCrossRefGoogle Scholar
  225. Lyman SD, Rohrschneider LR (1987) Analysis of functional domains of the v-fms- encoded protein of Susan McDonough strain sarcoma virus by linker insertion mutagenesis. Mol Cell Biol 7: 3287–3296PubMedGoogle Scholar
  226. Maki Y, Bos TJ, Davis C, Starbuck M, Vogt PK (1987) Avian sarcoma virus 17 carries the jun oncogene. Proc Natl Acad Sci USA 84: 2848–2852PubMedCrossRefGoogle Scholar
  227. Marth JD, Lewis DB, Wilson CB, Gearn ME, Krebs EG, Perlmutter RM (1987) Regulation of pp56lck during T-cell activation: functional implications for the src-like protein tyrosine kinases. EMBO J 6: 2727–2734PubMedGoogle Scholar
  228. Martin GS (1986) The erbB gene and the EGF receptor. Cancer Surv 5: 199–220PubMedGoogle Scholar
  229. Martin-Zanca D, Hughes SH, Barbacid M (1986) A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319: 743–748PubMedCrossRefGoogle Scholar
  230. Maxwell SA, Arlinghaus RB (1985) Use of site specific antipeptide antibodies to perturb the serine kinase catalytic activity of p37mos. J Virology 55: 874–876PubMedGoogle Scholar
  231. Maxwell SA, Arlinghaus RB (1985) Serine kinase activity associated with Moloney murine sarcoma virus-124-encodedp37mos. Virology 143: 321–333PubMedCrossRefGoogle Scholar
  232. Mayer BJ, Hamaguchi M, Hanafusa H (1988) A novel viral oncogene with structural similarity to phospholipase C. Nature 332: 272–275PubMedCrossRefGoogle Scholar
  233. McGrath JP, Capon DJ, Goeddel DV, Levinson AD (1984) Comparative biochemical properties of normal and activated human ras p21 protein. Nature 310: 644–649PubMedCrossRefGoogle Scholar
  234. Mercer ME, Nelson D, DeLeo AB, Old LJ, Baserga R (1982) Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. Proc Natl Acad Sci USA 79: 6309–6312PubMedCrossRefGoogle Scholar
  235. Merlino GT, Xu AH, Ishii S, Clark AJ, Semba K, Toyoshima K, Yamamoto T, Pastan I (1984) Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science 224: 417–419PubMedCrossRefGoogle Scholar
  236. Miller AD, Curran T, Verma IM (1984) c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell 36: 51–60Google Scholar
  237. Mitchell RL, Henning-Chubb C, Huberman E, Verma IM (1986) c-fos protein expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages. Cell 45: 497–504Google Scholar
  238. Moelling K, Pfaff E, Beug H, Beimling P, Bunte T, Schaller HE, Graf T (1985) DNA- binding activity is associated with purified myb proteins from AMV and E26 viruses and is temperature-sensitive for E26 ts mutants. Cell 40: 983–990PubMedCrossRefGoogle Scholar
  239. Molders H, Defesche J, Muller D, Bonner TI, Rapp UR, Muller R (1985) Integration of transfected LTR sequences into the c-raf proto-oncogene: activation by promoter insertion. EMBO J 4: 693–698PubMedGoogle Scholar
  240. Mulcahy LS, Smith MR, Stacey DW (1985) Requirement for ras proto-oncogene function during serum-stimulated growth of NIH-3T3-cells. Nature 313: 241–243PubMedCrossRefGoogle Scholar
  241. Muller R, Wagner E (1984) Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Nature 311: 438–442PubMedCrossRefGoogle Scholar
  242. Muller R, Bravo R, Burckhardt J, Curran T (1984) Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature 312: 716–720PubMedCrossRefGoogle Scholar
  243. Muller R, Muller D, Guillbert L (1986 a) Differential expression of c-fos in hematopoietic cells: correlation with differentiation of monomyelocytic cells in vitro. EMBO J 5: 311: 316Google Scholar
  244. Muller R, Muller D, Verrier B, Bravo R, Herbst H (1986 b) Evidence that expression of c-fos protein in amnion cells is regulated by external signals. EMBO 5: 311–316Google Scholar
  245. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu on-cogene. Cell 54: 105–115PubMedCrossRefGoogle Scholar
  246. Murray M, Cunningham J, Parada LF, Dautry F, Lebowitz P, Weinberg RA (1983) The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hemopoietic tumors. Cell 33: 749–757PubMedCrossRefGoogle Scholar
  247. Mushinski JF, Potter M, Bauer SR, Reddy EP (1983) DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas. Science 220: 795–798PubMedCrossRefGoogle Scholar
  248. Nakabeppu Y, Ryder K, Nathans D (1988) DNA binding activities of three murine jun proteins: stimulation by fos. Cell 55: 907–915PubMedCrossRefGoogle Scholar
  249. Neckameyer WS, Shibuya M, Hsu MT, Wang LH (1986) Proto-oncogene c-ros codes for a molecule with structural features common to those of growth factor receptors and displays tissue specific and developmentally regulated expression. Mol Cell Biol 6: 1478–1486PubMedGoogle Scholar
  250. Nedyalkov ST, Bozhkov SP, Todorov G (1975) Experimental erythroblastosis in the Japanese quail (Coturnix coturnix japonica) induced by E26 leukosis strain. Acta Vet (Brno) 44: 75–78Google Scholar
  251. Neel BG, Hayward WS, Robinson HL, Fang J, Astrin S (1981) Avian leukosis virus induced tumors have common proviral integration sites and synthesize discrete new RNA’s. Oncogenesis by promoter insertion. Cell 23: 323–334PubMedCrossRefGoogle Scholar
  252. Neil JC, Hughes D, McFarlane R, Wilie NM, Onions DE, Lees G, Jarret WO (1984) Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukemias. Nature 308: 814–820PubMedCrossRefGoogle Scholar
  253. Ness SA, Beug H, Graf T (1987) v-myb dominance over v-myc in doubly transformed chick myelomonocytic cells. Cell 51: 41–50Google Scholar
  254. Nilsen TW, Maroney PA, Goodwin RG, Rottman FM, Crittenden LB, Raines MA, Kung H (1985) c-erbB activation in ALV-induced erythroblastosis: novel RNA processing and promoter insertion result in expression of an amino-truncated EGF receptor. Cell 41: 719–726Google Scholar
  255. Nishizuka Y (1983) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693–698CrossRefGoogle Scholar
  256. Nishizuka Y (1986) Studies and perspectives of protein kinase C. Science 233: 305–312PubMedCrossRefGoogle Scholar
  257. Nishikura K, Murray JM (1987) Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells. Mol Cell Biol 7: 639–649PubMedGoogle Scholar
  258. Nomura N, Takahashi M, Matsui M, Ishii S, Date T, Sasamoto S, Ishizaki R (1988) Isolation of human cDNA clones of ray6-related genes, A-myb and B-myb. Nucl Acids Res 16: 11075–11089PubMedCrossRefGoogle Scholar
  259. Norman C, Runswick M, Pollock R, Treisman R (1988) Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 55: 989–1003PubMedCrossRefGoogle Scholar
  260. Nunn MF, Hunter H (1989) The ets sequence is required for induction of erythroblastosis in chickens by avian retrovirus E26. J Virol 63: 398–402PubMedGoogle Scholar
  261. Nunn MF, Seeburg PH, Moscovici C, Duesberg PH (1983 a) Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature 306: 391–395Google Scholar
  262. Nunn M, Weiher H, Bullock P, Duesberg P (1983 b) Avian erythroblastosis virus E26: nucleotide sequence of the tripartite one gene and of the LTR, and analysis of the cellular prototype of the viral ets sequence. Virology 133: 330–339Google Scholar
  263. Nusse R (1989) The int genes in mammary tumorigenesis and in normal development. Trends Genet 4: 291–295CrossRefGoogle Scholar
  264. Nusse R, Varmus HE (1982) Many tumors induced by the mouse mammary tumour virus contain a provirus integrated in the same region of the host genome. Cell 31: 99–109PubMedCrossRefGoogle Scholar
  265. Oker-Blom M, Hortling L, Kallio A, Nurmiaho EL, Westermarck H (1978) OKIO virus, an avian retrovirus resembling the acute leukaemia viruses. J Gen Virol 40: 623–633CrossRefGoogle Scholar
  266. Padhy LC, Shih C, Cowing D, Finklestein R, Weinberg RA (1982) Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell 28: 865–871PubMedCrossRefGoogle Scholar
  267. Papas TS, Bhat NK, Chen TT, Dubois G, Fisher RJ, Fujiwara S, Pribyl J, Saachi N, Seth A, Showaiter SD, Watson DK, Zweig M, Ascione R (1987) The ets gene in cells and viruses: implications for leukemias and other human diseases. In: Peschle C (ed) Normal and neoplastic blood cells: from genes to therapy. New York Academy of Sciences, pp 171–191Google Scholar
  268. Papkoff J, Brown AM, Varmus HE (1987) The int-1 proto-oncogene products are glycoproteins that appear to enter the secretory pathway. Mol Cell Biol 7: 3978–3984PubMedGoogle Scholar
  269. Parada LF, Land H, Weinberg RA, Wolf D, Rotter W (1984) Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature 312: 649–651PubMedCrossRefGoogle Scholar
  270. Paris S, Pouyssegur J (1986) Pertussis toxin inhibits thrombin-induced activation of phosphoinositide hydrolysis and Na+/H + exchange in hamster fibroblasts. EMBO J 5: 55–60PubMedGoogle Scholar
  271. Park M, Dean M, Cooper CS, Schmidt M, O’Brien SJ, Blair DG, Vande Woude GF (1986) Mechanism of met oncogene activation. Cell 45: 895–904PubMedCrossRefGoogle Scholar
  272. Parker PJ, Ullrich A (1987) Protein kinase C. J Cell Physiol 5: 53–56CrossRefGoogle Scholar
  273. Parsons SJ, Crentz CE (1986) p60src activity detected in the chromaffin granule membrane. Biochem Biophys Res Commun 134: 736–742Google Scholar
  274. Paulson Y, Hammacher A, Heldin CH, Westermark B (1987) Possible positive autocrine feedback in the prereplicative phase of human fibroblasts. Nature (London) 328: 715–717CrossRefGoogle Scholar
  275. Payne GS, Courtneidge SA, Crittenden LB, Fadly AM, Bishop JM, Varmus HE (1981) Analysis of avian leukosis virus DNA and RNA in bursal tumors: viral gene expression is not required for maintenance of the tumor state. Cell 23: 311–322PubMedCrossRefGoogle Scholar
  276. Payne GS, Bishop JM, Varmus HE (1982) Multiple arrangements of viral DNA and an activated host oncogene (c-myc) in bursal lymphomas. Nature 295: 209–214PubMedCrossRefGoogle Scholar
  277. Pellici PG, Lanfrancone L, Brathwaite MD, Wolman SR, Dalla Favera R (1984) Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science 225: 1117–1121CrossRefGoogle Scholar
  278. Persons DA, Wilkison WO, Bell RM, Finn OJ (1988) Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I DNA. Cell 52: 447–458PubMedCrossRefGoogle Scholar
  279. Persson H, Leder P (1984) Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene. Science 225: 718–720PubMedCrossRefGoogle Scholar
  280. Peters G, Brookes S, Smith R, Dickson C (1983) Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumours. Cell 38: 369–377CrossRefGoogle Scholar
  281. Piwnica-Worms H, Saunders KB, Roberts TM, Smith AE, Cheng SH (1987) Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell 49: 75–82PubMedCrossRefGoogle Scholar
  282. Pognonec P, Boulukos KE, Gesquiere JG, Stehelin D, Ghysdael J (1988) Mitogenic stimulation of thymocytes results in the calcium-dependent phosphorylation of c- ets-1 proteins. EMBO J 7: 977–983PubMedGoogle Scholar
  283. Ponder B (1988) Gene losses in human tumours. Nature 335: 400–402PubMedCrossRefGoogle Scholar
  284. Potter M, Reddy EP, Wivel NA (1978) Immunoglobulin production by lymphosarcomas induced by Abelson virus in mice. NCI Monogr 48: 311–321Google Scholar
  285. Preiss J, Loomis C, Bishop W, Stein R, Niedel J, Bell RM (1986) Quantitative measurement of sn-l,2-diacylglycerols present in platelets, hepatocytes and ras- and sis- transformed normal rat kidney cells. J Biol Chem 261: 8597–8600PubMedGoogle Scholar
  286. Prywes R, Roeder RG (1986) Inducible binding of a factor to the c-fas enhancer. Cell 47: 777–784PubMedCrossRefGoogle Scholar
  287. Quantin B, Breathnach R (1988) Epidermal growth factor stimulates transcription of the c-jun proto-oncogene in rat fibroblasts. Nature 334: 538–539PubMedCrossRefGoogle Scholar
  288. Quiafe CJ, Pinkert CA, Ornitz DM, Palmiter RD, Brinster R (1987) Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 48: 1023–1034CrossRefGoogle Scholar
  289. Rapp UR, Goldsborough MD, Mark GE, Bonner TI, Groffen J, Reynolds FH Jr, Stephenson J (1983) Structure and biological activity of v-raf, a unique oncogene in lung carcinogenesis. Proc Natl Acad Sci USA 80: 4218–4222PubMedCrossRefGoogle Scholar
  290. Rapp UR, Cleveland JL, Storm SM, Beck TW, Huleihel M (1986) Transformation by raf and myc oncogenes. Int Symp Princess Takamatsu Cancer Res Fund 17: 55–74Google Scholar
  291. Rapp UR, Cleveland JL, Bonner TI, Storm SM (1988) The raf oncogene. In: Reddy EP, Skalka AM, Curran T (eds) The oncogene handbook, Elsevier, Amsterdam, pp 213–253Google Scholar
  292. Reddy ES, Rao VN, Papas TS (1987) The erg gene: a human gene related to the ets oncogene. Proc Natl Acad Sci USA 84: 6131–6135PubMedCrossRefGoogle Scholar
  293. Reddy EP, Skalka AM, Curran T (1988) The oncogene handbook. Elsevier AmsterdamGoogle Scholar
  294. Reed JC, Alpers JD, Scherle PA, Hoover RG, Nowell PC, Prystowsky MB (1987) Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression. Oncogene 1: 223–228PubMedGoogle Scholar
  295. Renz M, Verrier B, Kurz C, Muller R (1987) Chromatin association and DNA binding properties of the c-fas proto-oncogene product. Nucl Acids Res 15: 277–292PubMedCrossRefGoogle Scholar
  296. Reynolds AB, Vila J, Lansing TJ, Potts WM, Weber MJ, Parsons JT (submitted) Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy-terminus.Google Scholar
  297. Rijsewijk F, Schuermann M, Wagenaar E, Parren C, Weidel D, Nusse R (1987 a) The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 50: 649–657CrossRefGoogle Scholar
  298. Rijsewijk F, van Deemter L, Wagenaar E, Sonnenberg A, Nusse R (1987 b) Transfection of the int-1 mammary oncogene in cuboidal RAC mammary cell line results in morphological transformation and tumorgenicity. EMBO J 6: 127–131Google Scholar
  299. Robbins KC, Devare SG, Reddy EP, Aaronson SA (1982 a) In vivo identification of the transforming gene product of simian sarcoma virus. Science 218:1131–1133CrossRefGoogle Scholar
  300. Robbins KC, Hill RL, Aaronson SA (1982 b) Primate origin of the cell-derived sequences of simian sarcoma virus. J Virol 41. 721–725Google Scholar
  301. Robbins KC, Antoniades HN, Devare SG, Hunkapiller MW, Aaronson SA (1983) Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor. Nature 305: 605–608PubMedCrossRefGoogle Scholar
  302. Robbins KC, Leal F, Pierce JH, Aaronson SA (1985) The v-sis/PDGF-2 transforming gene product localizes to cell membranes but is not a secretory protein, EMBO J 4: 1783–1792PubMedGoogle Scholar
  303. Rogelj S, Weinberg RA, Fanning P, Klagsbrun M (1988) Basic fibroblast growth factor fused to signal peptide transforms cells. Nature 331: 173–175PubMedCrossRefGoogle Scholar
  304. Rollins BJ, Morrison ED, Stiles CD (1988) Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc Natl Acad Sci USA 85: 3738–3742PubMedCrossRefGoogle Scholar
  305. Rosenthal A, Lindquist PB, Bringman TS, Goeddel DV, Derynck R (1986) Expression in rat fibroblasts of a human transforming growth factor-(alpha) cDNA results in transformation. Cell 46: 301–309PubMedCrossRefGoogle Scholar
  306. Rous P (1911) A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13: 397–411PubMedCrossRefGoogle Scholar
  307. Roussel MF, Säule S, Lagrou C, Rommens C, Beug H, Graf T, Stehelin D (1979) Three new types of viral oncogenes of cellular origin specific for haematopoietic cell transformation. Nature 281: 425–455CrossRefGoogle Scholar
  308. Roussel MF, Rettenmier CW, Look AT, Sherr CJ (1984) Cell surface expression of v-yww-coded glycoproteins is required for transformation. Mol Cell Biol 4: 1999–2009PubMedGoogle Scholar
  309. Roussel MF, Downing JR, Rettenmier CW, Sherr CJ (1988) A point mutation in the extracellular domain of the human CSF-1 receptor (c-fins proto-oncogene product) activates its transforming potential. Cell 55: 979–988PubMedCrossRefGoogle Scholar
  310. Royer-Pokora B, Beug H, Claviez M, Winkhardt H-J, Friis RR, Graf T (1978) Transformation parameters in chicken fibroblasts transformed by AEV and MC29 avian leukemia viruses. Cell 13: 751–750Google Scholar
  311. Rüther U, Garber C, Komitowski D, Muller R, Wagner EF (1987) Deregulated c-fas expression interferes with normal bone development in transgenic mice. Nature 325: 412–416PubMedCrossRefGoogle Scholar
  312. Ryder K, Lau L, Nathans D (1988) A gene activated by growth factors is related to the oncogene v-jun. Proc Natl Acad Sci USA 85: 1487–1491PubMedCrossRefGoogle Scholar
  313. Ryseck R-P, Hirai SI, Yaniv M, Bravo R (1988) Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature 334: 535–537PubMedCrossRefGoogle Scholar
  314. Ryseck R-P, MacDonald-Bravo H, Mattei MG, Bravo R (1989) Cloning and sequence of a secretory protein induced by growth factors in mouse fibroblasts. Exp Cell Res 180: 266–275PubMedCrossRefGoogle Scholar
  315. Sacca R, Stanley ER, Sherr CJ, Rettenmeier CW (1986) Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v- fms oncogene. Proc Natl Acad Sci USA 83: 3331–3335PubMedCrossRefGoogle Scholar
  316. Sakamoto H, Yoshida T, Nakakuki M, Odagiri H, Miyagawa K, Sugimura T, Terada M (1988) Cloned hst gene from normal human leukocyte DNA transforms NIH3T3 cells. Biochem Biophy Res Commun 151: 965–972CrossRefGoogle Scholar
  317. Samarut J, Gazzolo L (1982) Target cells infected by avian erythroblastosis virus differentiate and become transformed. Cell 28: 921–929PubMedCrossRefGoogle Scholar
  318. Sambucetti LC, Curran T (1986) The fas protein complex is associated with DNA in isolated nuclei and binds to DNA cellulose. Science 234: 1417–1419PubMedCrossRefGoogle Scholar
  319. Sap J, Munoz A, Damm K, Ghysdael J, Leutz A, Beug H, Vennström B (1986) The c-erbA protein is a high affinity receptor for thyroid hormone. Nature 324: 635–640PubMedCrossRefGoogle Scholar
  320. Sariban E, Luebbers R, Kufe D (1988) Transcriptional and posttranscriptional control of c-fas gene expression in human monocytes. Mol Cell Biol 8: 340–346PubMedGoogle Scholar
  321. Sassone-Corsi P, Ransone LJ, Lamph WE, Verma IM (1988 a) Direct interaction between fas and jun nuclear oncoproteins: role of the leucine zipper domain. Nature 336: 692–695Google Scholar
  322. Sassone-Corsi P, Lamph WW, Kamps M, Verma IM (1988 b) /05-associated cellular p39 is related to nuclear transcription factor AP-1. Cell 54: 553–560CrossRefGoogle Scholar
  323. Sassone-Corsi P, Sisson JC, Verma IM (1988 c) Transcriptional autoregulation of the proto-oncogene fas. Nature 334:314–319Google Scholar
  324. Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, Weinberg RA (1984) The neu oncogene: an erbB-related gene encoding a 185,000-Mr tumor antigen. Nature 312: 513–516PubMedCrossRefGoogle Scholar
  325. Schönthal A, Herrlich P, Rahmsdorf HJ, Ponta H (1988) Requirement for fas gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 54: 325–334PubMedCrossRefGoogle Scholar
  326. Schwab M (1985) Amplification of N-myc in human neuroblastomas. Trends Genet 1: 271–275CrossRefGoogle Scholar
  327. Schwab M (1986) Amplification of proto-oncogenes and tumor progression. In: Kahn P, Graf T (eds) Oncogenes and growth control. Springer, Berlin Heidelberg New York, pp 332–339CrossRefGoogle Scholar
  328. Schwab M, Ellison J, Busch M, Rosenau W, Varmus HE, Bishop JM (1984) Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA 81: 4940–4944PubMedCrossRefGoogle Scholar
  329. Schwab M, Varmus HE, Bishop JM (1985) The human N-myc gene contributes to tumorigenic conversion of mammalian cells in culture. Nature 316: 160–162PubMedCrossRefGoogle Scholar
  330. Sealy L, Privalsky ML, Moscovici G, Moscovici C, Bishop JM (1983) Site-specific mutagenesis of avian erythroblastosis virus: erbB is required for oncogenicity. Virology 130: 155–178PubMedCrossRefGoogle Scholar
  331. Semba K, Kamata N, Toyoshima K, Yamamoto T (1985) A v-erbB related protoon- cogene, c-erbB-2 is distinct from the c-erbB-1 /epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA 82: 6497–6501PubMedCrossRefGoogle Scholar
  332. Seth A, Priel E, Vande Woude GF (1987) Nucleoside triphosphate-dependent nucleic-acid-binding properties of mos protein. J Virol 56: 144–152Google Scholar
  333. Setoyama C, Frunzio R, Lian G, Mudryi M, De Combrugghe B (1986) Transcriptional activation encoded by the v-fos gene. Proc Natl Acad Sci USA 83: 3213–3217PubMedCrossRefGoogle Scholar
  334. Shackleford GM, Varmus HE (1987) Expression of the proto-oncogene int-1 is restricted to postmeiotic male germ cells and the neural tube of mid-gestational embryos. Cell 50: 89–95PubMedCrossRefGoogle Scholar
  335. Shalloway D, Coussens PM, Yaciuk P (1984) Overexpression of the c-src protein does not induce transformation of NIH 3T3 cells. Proc Natl Acad Sci USA 81: 7071–7075PubMedCrossRefGoogle Scholar
  336. Shen-Ong GLC, Morse HC, Potter M, Mushinski JF (1986) Two modes of c-myb activation in virus-induced mouse myeloid tumors. Mol Cell Biol 6: 380–392Google Scholar
  337. Sherr CJ (1987) Fibroblast and hematopoietic cell transformation by the fms oncogene (CSF-1 receptor). J Cell Physiol 5: 83–87CrossRefGoogle Scholar
  338. Sherr CJ (in press) The fms oncogene. BBA Rev Cancer (in press) Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER (1985) The c- fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor. Cell 41:665–676Google Scholar
  339. Shibuya M, Hanafusa H, Balduzzi PC (1982) Cellular sequences related to three new one genes of avian sarcoma virus (fps, yes, and ros) and their expression in normal and transformed cells. J Virol 42: 143–152PubMedGoogle Scholar
  340. Shih C, Padhy LC, Murray M, Weinberg RA (1981) Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261–264PubMedCrossRefGoogle Scholar
  341. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P (1987) Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49: 465–475PubMedCrossRefGoogle Scholar
  342. Skouv J, Christensen B, Skibski L, Autrup H (1986) The skin tumor-promoter 12-0- tetradecanoyolphorbol-13-acetate induces transcription of the c-fos proto- oncogene in human bladder epithelial cells. Carcinogenesis 7: 331–333PubMedCrossRefGoogle Scholar
  343. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER- 2/neu oncogene. Science 235: 177–182PubMedCrossRefGoogle Scholar
  344. Small M, Hay N, Ramsay G, Schwab M, Bishop JM (1987) N-myc induces tumorigenic conversion of cultured rat cells. Mol Cell Biol 7: 1638–1645PubMedGoogle Scholar
  345. Smith MR, DeGudicibus SJ, Stacey DW (1986) Requirement for c-ras proteins during viral oncogene transformation. Nature 320: 540–543PubMedCrossRefGoogle Scholar
  346. Sorrentino V, Drozdoff V, McKinney MD, Zeitz L, Fleissner E (1986) Potentiation of growth factor activity by exogenous c-myc expression. Proc Natl Acad Sci USA 83: 8167–8171PubMedCrossRefGoogle Scholar
  347. Sporn MB, Todaro GJ (1980) Autocrine secretion and malignant transformation of cells. N Engl J Med 303: 878–880PubMedCrossRefGoogle Scholar
  348. Spurr NK, Solomon E, Jansson M, Sheer D, Goodfellow PN, Bodmer WF, Vennstrom B (1984) Chromosomal localization of the human homologues to the oncogenes erbA and B. EMBO J 3: 159–163PubMedGoogle Scholar
  349. Stacey DW, Kung HF (1984) Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein. Nature 310: 508–511PubMedCrossRefGoogle Scholar
  350. Stacey DW, Watson T, Kung HF, Curran T (1987) Microinjection of transforming ras protein induces c-fos expression. Mol Cell Biol 7: 523–527PubMedGoogle Scholar
  351. Stern DF, Hare DL, Ceccini MA, Weinberg RA (1987) Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. Science 235: 321–324PubMedCrossRefGoogle Scholar
  352. Stewart TA, Pattengale PK, Leder P (1984) Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38: 627–637PubMedCrossRefGoogle Scholar
  353. Stocking C, Loliger C, Kawai M, Suciu S, Gough N, Ostertag W (1988) Identification of genes involved in growth autonomy of hematopoietic cells by analysis of factor- independent mutants. Cell 53: 869–879PubMedCrossRefGoogle Scholar
  354. Struhl K (1987) The DNA-binding domains of the jun oncoprotein and the yeast GCN4 transcriptional activator proteins are functionally homologous. Cell 50: 841–846PubMedCrossRefGoogle Scholar
  355. Struhl K (1988) The JUN oncoprotein, a vertebrate transcription factor, activates transcription in yeast. Nature 332: 649–650PubMedCrossRefGoogle Scholar
  356. Suarez HG, Nardeux PC, Andeol Y, Sarasin A (1987) Multiple activated oncogenes in human tumors. Oncogene Res 1: 201–207Google Scholar
  357. Sukhatme VP, Cao X, Chang LC, Tsai-Morris C-H, Stamenkovich D, Ferreira PCP, Cohen DR, Edwards SA, Shows TB, Curran T, Le Beau MM, Adamson ED (1988) A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53: 37–43PubMedCrossRefGoogle Scholar
  358. Sweet RW, Yokoyama S, Kamata T, Feramisco R, Rosenberg M, Gross M (1984) The product of ras is a GT Pase and the T24 oncogenic mutant is deficient in this activity. Nature 311: 273–275PubMedCrossRefGoogle Scholar
  359. Taira M, Yoshida T, Miyagawa K, Sakamoto H, Terada M, Sugimura T (1987) cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc Natl Acad Sci USA 84: 2980–2984Google Scholar
  360. Takahashi M, Cooper GM (1987) ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 7: 1378–1385Google Scholar
  361. Tam JP, Marquardt H, Rosberger DF, Wong TW, Todaro GJ (1984) Synthesis of biologically active rat transforming growth factor I. Nature 309: 376–378PubMedCrossRefGoogle Scholar
  362. Tamura T, Simon E, Niemann H, Snoek GT, Bauer H (1986) gpl40-v-fms molecules expressed at the surface of cells transformed by the McDonough strain of feline sarcoma virus are phosphorylated in tyrosine and serine. Mol Cell Biol 6: 4745–748Google Scholar
  363. Tempest PR, Cooper CS, Major GN (1986) The activated human met gene encodes a protein tyrosine kinase. FEBS Lett 209: 357–361PubMedCrossRefGoogle Scholar
  364. Thomas G, Martin-Perez J, Siegmann M, Otto AM (1982) The effect of serum, EGF, PGF2 alpha and insulin on S6 phosphorylation and the initiation of protein and DNA synthesis. Cell 30: 235–242PubMedCrossRefGoogle Scholar
  365. Thompson CB, Challoner PB, Neiman PE, Groudine M (1986) Expression of the c-myb proto-oncogene during cellular proliferation. Nature 319: 374–380PubMedCrossRefGoogle Scholar
  366. Trahey M, McCormick F (1987) A cytoplasmic protein stimulates normal N-ras p21 GT Pase, but does not affect oncogenic mutants. Science 238: 542–545PubMedCrossRefGoogle Scholar
  367. Treisman R (1985) Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5’ element and c-fos 3’ sequences. Cell 42: 889–902PubMedCrossRefGoogle Scholar
  368. Treisman R (1986) Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46: 567–574PubMedCrossRefGoogle Scholar
  369. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309: 418–425PubMedCrossRefGoogle Scholar
  370. Ushiro H, Cohen S (1980) Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Biol Chem 255: 8363–8365PubMedGoogle Scholar
  371. Van Beveren C, Verma IM (1985) Homology among oncogenes. Curr Top Microbiol 123: 73–98CrossRefGoogle Scholar
  372. Van Beveren C, Van Straaten F, Galleshaw JA, Verma IM (1981) Nucleotide sequence of the genome of a murine sarcoma virus. Cell 27: 97–108PubMedCrossRefGoogle Scholar
  373. Van Beveren C, Van Straaten F, Curran T, Muller R, Verma IM (1983) Analysis of FBJ-Mu SV provirus and c-fas (mouse) gene reveals that viral and cellular fas gene products have different carboxyttermini. Cell 32: 1241–1255PubMedCrossRefGoogle Scholar
  374. Van Ooyen A, Nüsse R (1984) Structure and nucleotide sequence of the putative mammary oncogene int-1; proviral insertions leave the protein-encoding domain intact. Cell 39: 233–240PubMedCrossRefGoogle Scholar
  375. Van Ooyen A, Kwee V, Nüsse R (1985) The nucleotide sequence of the human int-1 mammary oncogene; evolutionary conservation of coding and non-coding sequences. EMBO J 4: 2905–2909PubMedGoogle Scholar
  376. Van Straaten F, Muller R, Curran T, Van Beveren C, Verma IM (1983) Complete nucleotide sequence of human c-one gene: deduced amino acid sequence of the human c-fas gene protein. Proc Natl Acad Sci USA 80: 3183–3187PubMedCrossRefGoogle Scholar
  377. Veillette A, Horak I, Horak EM, Bookman MA, Bolen JB (1988) Alterations of the lymphocyte-specific protein tyrosine kinase (p561ck) during T-cell activation. Mol Cell Biol 8: 4353–4361PubMedGoogle Scholar
  378. Velu TJ, Beguinot L, Vass WS, Willingham MC, Merlino GT, Pastan I, Lowy DR (1987) Epidermal growth factor-dependent transformation by a human EGF receptor proto-oncogene. Science 238: 1408–1410PubMedCrossRefGoogle Scholar
  379. Vennström B, Bishop JM (1982) Isolation and characterization of chicken DNA homologous to the two putative oncogenes of avian erythroblastosis virus. Cell 28: 135–143PubMedCrossRefGoogle Scholar
  380. Verma IM, Lai MHT, Bosselman RA, McKennett MA, Fan H, Berns A (1980) Molecular cloning of unintegrated Moloney mouse sarcoma virus. Proc Natl Acad Sci USA 77: 1773–1777PubMedCrossRefGoogle Scholar
  381. Vogel US, Dixon RAF, Schaber MD, Diehl RE, Marshall MS, Scolnick EM, Sigal IS, Gibbs JB (1988) Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature 335: 90–93Google Scholar
  382. Vogt P, Tjian R (1988) Jun: a transcriptional regulator turned oncogenic. Oncogene 3: 3–7Google Scholar
  383. Vogt PK, Bos TJ, Doolittle RF (1987) Homology between the DNA-binding domain of the GCN4 regulatory protein of yeast and the carboxyl-terminal region of a protein coded for by the oncogene jun. Proc Natl Acad Sci USA 84: 3316–3319PubMedCrossRefGoogle Scholar
  384. von Weizsäcker F, Beug H, Graf T (1986) Temperature-sensitive mutants of MH2 avian leukemia virus that map in the v-mil and the v-myc oncogene respectively. EMBO J 5: 1521–1527Google Scholar
  385. Wasylyk C, Imler JL, Wasylyk B (1988) Transforming but not immortalizing on-cogenes activate the transcription factor PEA1. EMBO J 7: 2475–2483PubMedGoogle Scholar
  386. Watanabe S, Lazar E, Sporn MB (1987) Transformation of normal rat kidney ( NRK) cells by an infectious retrovirus carrying a synthetic rat type (alpha) transforming growth factor gene. Proc Natl Acad Sci USA 84: 1258–1262PubMedCrossRefGoogle Scholar
  387. Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson A, Westermark B, Heldin C-H, Huang HS, Deuel TF (1983) Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304: 35–39PubMedCrossRefGoogle Scholar
  388. Watson DK, McWilliams M, Papas TS (1988) Molecular organization of the chicken ets locus. Virology 164: 99–105PubMedCrossRefGoogle Scholar
  389. Weinberg RA (1985) The action of oncogenes in the cytoplasm and nucleus. Science 230: 770–776PubMedCrossRefGoogle Scholar
  390. Weinberger C, Thompson EC, Ong ES, Lebo R, Gruol DJ, Evans RM (1986) The c- erbA gene encodes a thyroid hormone receptor. Nature 324: 641–646PubMedCrossRefGoogle Scholar
  391. Weinstein Y, Ihle JN, Lavu S, Reddy EP (1986) Truncation of the c-myb gene by a retroviral integration in an interleukin 3-dependent myeloid leukemia cell line. Proc Natl Sci USA 83: 5010–5014CrossRefGoogle Scholar
  392. Westin EH, Gallo RC, Arya SK, Eva A, Souza LM, Baluda MA, Aaronson SA, Wong- Staal F (1982) Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci USA 79: 2194–2198PubMedCrossRefGoogle Scholar
  393. Wheeler EF, Rettenmier CW, Look AT, Sherr CJ (1986) The 1-fms oncogene induces factor independence and tumorigenicity in a CSF-1 dependent macrophage cell line. Nature 234: 377–380CrossRefGoogle Scholar
  394. Wickstrom EL, Bacon TA, Gonzales A, Freeman DL, Lyman GH, Wickstrom E (1988) Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by a antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci USA 85: 1028–1032PubMedCrossRefGoogle Scholar
  395. Wieschaus E, Riggelman R (1987) Autonomous requirements for the segment polarity gene armadillo during Drosophila embryogenesis. Cell 49: 177–194PubMedCrossRefGoogle Scholar
  396. Wilkinson DG, Bailes J A, McMahon AP (1987) Expression of the proto-oncogene int-1 is restricted to specific neural cells in the developing mouse embryo. Cell 50: 79–88PubMedCrossRefGoogle Scholar
  397. Wilkinson DG, Peters G, Dickson C, McMahon AP (1988) Expression of the FGF- related proto-oncogene int-2 during gastrulation and neurulation in the mouse. EMBO J 7: 691–695PubMedGoogle Scholar
  398. Witte ON (1986) Functions of the abl oncogene. Cancer Surv 5: 183–197PubMedGoogle Scholar
  399. Wolfe LG, Deinhardt F, Theilen GJ, Rabin H, Kawakami T, Bustad LK (1971) Induction of tumors in marmoset monkeys by simian sarcoma virus, type 1 ( Lagothrix) a preliminary report. J Natl Cancer Inst 47: 1115–1120PubMedGoogle Scholar
  400. Wong PMC, Chung S-W, Nienhuis AW (1987) Retroviral transfer and expression of the interleukin-3 gene in hemopoietic cells. Genes Dev 1: 358–365PubMedCrossRefGoogle Scholar
  401. Wood TG, McGeady ML, Baroudy BM, Blair DG, Vande Woude GF (1984) Mouse c- mos oncogene activation is prevented by upstream sequences. Proc Natl Acad Sci USA 81: 7817–7821PubMedCrossRefGoogle Scholar
  402. Woolford J, McAuliffe A, Rohrschneider LR (1988) Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype. Cell 55: 965–977PubMedCrossRefGoogle Scholar
  403. Yamada G, Kitamura Y, Sonoda H, Harada H, Taki S, Mulligan RC, Osawa H, Diamantstein T, Yokoyama S, Taniguchi T (1987) Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity. EMBO J 6: 2705–2709PubMedGoogle Scholar
  404. Yamamoto T, Nishida T, Mitajimi N, Kawai S, Ooi T, Toyoshima K (1983) The erbB gene of avian erythroblastosis virus is a member of the src gene family. Cell 35: 71–78PubMedCrossRefGoogle Scholar
  405. Yamamoto T, Hihara H, Nishida T, Kawai S, Toyoshima K (1983) A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas. Cell 34: 225–232PubMedCrossRefGoogle Scholar
  406. Yancopoulos GD, Nisen PD, Tesfaye A, Kohl N, Goldfarb MP, Alt F (1985) N-myc can cooperate with ras to transform normal cells in culture. Proc Nat Acad Sci USA 82: 5455–5459PubMedCrossRefGoogle Scholar
  407. Yarden J, Ullrich A (1988) Growth factor receptor tyrosine kinases. Ann Rev Biochem 57: 443–478PubMedCrossRefGoogle Scholar
  408. Yarden Y, Schlessinger J (1987) Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26: 1443–1451PubMedCrossRefGoogle Scholar
  409. Yarden Y, Escobedo JA, Kuang W-J, Yang-Feng TL, Daniel TO, Tremble PM, Chen EY, Ando ME, Harkins RN, Francke U, Fried VA, Ullrich A, Williams LT (1986) Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323: 226–232PubMedCrossRefGoogle Scholar
  410. Yoshida MC, Wada M, Satoh H, Yoshida T, Sakamoto H, Miyagawa K, Yokota J, Koda T, Kakinuma M, Sugimura T (1988) Human HST1 (HSTF1) gene maps to chromosome band 1 lql3 and coamplifies with the int-2 gene in human cancer. Proc Natl Acad Sci USA 85: 4861–4864PubMedCrossRefGoogle Scholar
  411. Yoshida T, Migyagawa K, Odagiri H, Sakamoto H, Little PF, Terada M, Sugimura T (1987) Genomic sequences of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2 encoded protein. Proc Natl Acad Sci USA 84: 305–309CrossRefGoogle Scholar
  412. Yu YH, Richert N, Ito S, Merlino GT, Pastan I (1984) Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc Natl Acad Sci USA 81: 7308–7312CrossRefGoogle Scholar
  413. Yuan CC, Kan N, Dunn KJ, Papas TS, Blair DG (1988) Properties of a murine retroviral recombinant of avian acute leukemia virus E26: a murine fibroblast assay for V-ets function. J Virol 63: 205–215Google Scholar
  414. Zhan X, Bates B, Hu X, Goldfarb M (1988) The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. Mol Cell Biol 8: 3487–3495PubMedGoogle Scholar
  415. Zenke M, Kahn P, Disela C, Vennstrom B, Leutz A, Keegan K, Hayman MJ, Choi H-R, Yew N, Engel JD, Beug H (1988) v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (Band 3) gene. Cell 1988 52: 107–119PubMedCrossRefGoogle Scholar
  416. Zerial M, Toschi L, Ryseck R-P, Schuermann M, Müller R, Bravo R (1989) The product of a novel growth factor-activated gene, fosB, interacts with JUN proteins enhancing their DNA binding activity (submitted for publication)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • A. Leutz
  • T. Graf

There are no affiliations available

Personalised recommendations